US Patent 11999753 Tetrahydropyridopyrimidine pan-KRas inhibitors
Patent 11999753 was granted and assigned to Mirati Therapeutics on June, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11999753 Tetrahydropyridopyrimidine pan-KRas inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
